Monitoring of cytomegalovirus, Epstein-Barr virus and adenovirus infections in hematopoietic stem cell transplant recipients
Abstract
Purpose: Haematopoietic stem cell transplant (HSCT) recipients with iatrogenic immunosuppression are high-risk patients for viral infections. The aim of this study was to investigate the incidence of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus (ADV) infections in HSCT recipients.
Materials and Methods: We prospectively monitored 35 patients aged 0-17 years who had allogeneic (n=30) and autologous (n=5) HSCT by quantitative real-time polymerase chain reaction tests for CMV, EBV, and ADV. The monitoring was performed one week before HSCT and weekly for the first 100 days, once a month up to one year after HSCT. In addition, seropositivity for viruses was analysed by Enzyme-Linked Immuno Sorbent Assay a week before transplantation.
Results: Before transplantation, all 35 (100%) patients who underwent HSCT were CMV IgG positive, 30 (85.7% - 95% CI: 74.1%-97.3%) HSCT recipients were found to be EBV IgG positive. CMV infection was found in 24 (80% - 95% CI: 65.7%-94.3%), ADV infection in 11 (36.7% - 95% CI: 19.4%-53.9%) and EBV infection in 8 (26.7% - 95% CI: 10.8%-42.5%) allogeneic HSCT patients. In this group, CMV DNA viral load in 8 (26.7%) patients, of which one (3.3%) coinfected with EBV DNA and one (3.3%) with ADV DNA, was higher than 1000 copies/mL which was required for pre-emptive treatment. Among 5 autologous HSCT recipients, CMV DNA was detected in 2 patients, EBV DNA in 5 and ADV DNA in 2. Pre-emptive treatment was given to 11 (%31.4 - 95% CI: 16%-46.8%; 6 CMV, 2 EBV, 1 ADV, 1 CMV-EBV and 1 CMV-ADV infection) of 35 patients. Thus, the development of viral disease was prevented in 7 (63.6% - 95% CI: 35.2%-92.1%). Of the total 35 patients, only 2 (5.7% - 95% CI: 0.0%-13.4%) died due to viral infection.
Conclusion: Early diagnosis of viral infections by prospective monitoring of viral loads in HSCT patients would be effective in preventing morbidity and mortality by ensuring timely initiation of pre-emptive therapy.
Keywords
Kaynakça
- Wölfl M, Qayed M, Benitez Carabante MI, Sykora T, Bonig H, Lawitschka A et al. Current prophylaxis and treatment approaches for acute graft-versus-host disease in haematopoietic stem cell transplantation for children with acute lymphoblastic leukaemia. Front Pediatr. 2022;9:784377.
- Annaloro C, Serpenti F, Saporiti G, Galassi G, Cavallaro F, Grifoni F etal. Viral infections in HSCT: detection, monitoring, clinical management, and immunologic implications. Front Immunol. 2021;11:569381.
- Xuan L, Huang F, Fan Z, Zhou H, Zhang X, Yu G et al. Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies. J Hematol Oncol. 2012;5:46.
- Rojas-Rechy MH, Gaytán-Morales F, Sánchez-Ponce Y, Castorena-Villa I, López-Martínez B, Parra-Ortega I et al Herpesvirus screening in childhood hematopoietic transplant reveals high systemic inflammation in episodes of multiple viral detection and an EBV association with elevated IL-1β, IL-8 and Graft-Versus-Host Disease. Microorganisms. 2022;10:1685.
- Ukonmaanaho EM, Alexandersson A, Mannonen L, Lautenschlager I, Taskinen M, Koskenvuo M. Respiratory viruses after paediatric allogenic haematopoietic stem cell transplantation. Infect Dis. 2021;53:214˗7.
- Wang X, Patel SA, Haddadin M, Cerny J. Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus. Ther Adv Infect Dis. 2021;24:20499361211018027.
- Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021;19:759–73.
- Zajac-Spychala O, Kampmeier S, Lehrnbecher T, Groll AH. Infectious complications in paediatric haematopoietic cell transplantation for Acute Lymphoblastic Leukaemia: Current Status. Front Pediatr. 2022;9:782530.
- Burrell CJ, Howard CR, Murphy FA. Laboratory Diagnosis of virus diseases. Fenner and White's Med Virol. 2017;135˗54.
- Düver F, Weißbrich B, Eyrich M, Wölfl M, Schlegel PG, Wiegering V. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - a single center 11-year analysis. PLoS One. 2020;15:e02284511–17.
